Home
At a glance
Contact us
Home
»
Media
»
Press Releases
Debio 0932
Date
Article Title
16 Feb 2012
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932
27 Apr 2010
Debiopharm Group™ starts Phase I clinical trial with Debio 0932
06 Aug 2009
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
Latest News
15 May 2012
Debiopharm and Vifor Pharma sign an exclusive agreement for the distribution and commercialization of Pamorelin® LA in Switzerland - A drug treatment for prostate cancer and endometriosis
16 February 2012
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932
09 November 2011
Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease
About us
Our business
Responsibility
Careers
Media
Press Releases
Publications
Download center
Events
Debiopharm on
Legal Notice
CSOnline
Credits
Sitemap
© 2012 Debiopharm Group
